Fundraising Fox

Laia Crespo

Investor

Partner at Sanofi Ventures

Paris, France

Writes $5M – $10M checks · typically $7.5M

About

Laia Crespo, a Cambridge PhD with chemistry training, sits on the boards of QurAlis, Therini Bio and Muna Therapeutics and architects new companies around neurodegeneration and genetic medicines.

Contact· self-published, not guessed

Invests in

AI & Machine LearningBiotechData & InfrastructureHealthtechMedical Devices

Experience

  1. SanofiPartner - Sanofi Venturescurrent2018 — presentParis
  2. Ysios CapitalInvestment Director2015 — 2018
  3. Ysios CapitalInvestment Manager2009 — 2015Barcelona, Catalonia, Spain
  4. Johnson & JohnsonNew Business Development Analyst for Europe, Middle East and Africa2008 — 2009
  5. UCBResearch Scientist2007Cambridge, England, United Kingdom
  6. Medivir ABResearch Scientist2004 — 2007Cambridgeshire, England, United Kingdom
  7. Spirogen (now AstraZeneca)Research Scientist2002 — 2003London, England, United Kingdom

Colleagues at Sanofi Ventures

Network2

Investors connected to Laia in public investor directories — a warm-intro map.

Frequently asked questions

Who is Laia Crespo?
Laia Crespo, a Cambridge PhD with chemistry training, sits on the boards of QurAlis, Therini Bio and Muna Therapeutics and architects new companies around neurodegeneration and genetic medicines.
Where does Laia Crespo work?
Laia Crespo is Partner at Sanofi Ventures.
What does Laia Crespo invest in?
Laia Crespo invests in AI & Machine Learning, Biotech, Data & Infrastructure, Healthtech, Medical Devices.
What check size does Laia Crespo write?
Laia Crespo typically writes checks of $5M – $10M.
Where did Laia Crespo go to school?
Laia Crespo studied at University of Cambridge (MBA, Master in Business Administration); Universitat de Barcelona (First Degree, MSc and PhD); Liceu Music Conservatoire (Bachelors Degree, Piano and Music Theory).

Same school

Shared employers